Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.

Olliaro P, Vaillant M, Arana B, Grogl M, Modabber F, Magill A, Lapujade O, Buffet P, Alvar J.

PLoS Negl Trop Dis. 2013;7(3):e2130. doi: 10.1371/journal.pntd.0002130. Epub 2013 Mar 21.

PMID:
23556016
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Designing and reporting clinical trials on treatments for cutaneous leishmaniasis.

González U, Pinart M, Reveiz L, Rengifo-Pardo M, Tweed J, Macaya A, Alvar J.

Clin Infect Dis. 2010 Aug 15;51(4):409-19. doi: 10.1086/655134. Review.

PMID:
20624067
[PubMed - indexed for MEDLINE]
Free Article
3.

Leishmaniasis chemotherapy--challenges and opportunities.

Croft SL, Olliaro P.

Clin Microbiol Infect. 2011 Oct;17(10):1478-83. doi: 10.1111/j.1469-0691.2011.03630.x. Review.

PMID:
21933306
[PubMed - indexed for MEDLINE]
4.

Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials.

Kim DH, Chung HJ, Bleys J, Ghohestani RF.

PLoS Negl Trop Dis. 2009;3(2):e381. doi: 10.1371/journal.pntd.0000381. Epub 2009 Feb 17.

PMID:
19221595
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment.

Mitropoulos P, Konidas P, Durkin-Konidas M.

J Am Acad Dermatol. 2010 Aug;63(2):309-22. doi: 10.1016/j.jaad.2009.06.088. Epub 2010 Mar 19. Review.

PMID:
20303613
[PubMed - indexed for MEDLINE]
6.

A Therapeutic update on Cutaneous leishmaniasis.

Bari AU, Rahman SB.

J Coll Physicians Surg Pak. 2003 Aug;13(8):471-6. Review.

PMID:
12921689
[PubMed - indexed for MEDLINE]
7.

Interventions for Old World cutaneous leishmaniasis.

González U, Pinart M, Reveiz L, Alvar J.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD005067. doi: 10.1002/14651858.CD005067.pub3. Review.

PMID:
18843677
[PubMed - indexed for MEDLINE]
8.

Cutaneous leishmaniasis.

Khatami A, Firooz A, Gorouhi F, Khamesiour A, Dowlati Y.

Lancet Infect Dis. 2008 Aug;8(8):458; author reply 458-9. doi: 10.1016/S1473-3099(08)70159-2. No abstract available.

PMID:
18652987
[PubMed - indexed for MEDLINE]
9.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

PMID:
12869717
[PubMed - indexed for MEDLINE]
Free Article
10.

LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.

Blum J, Buffet P, Visser L, Harms G, Bailey MS, Caumes E, Clerinx J, van Thiel PP, Morizot G, Hatz C, Dorlo TP, Lockwood DN.

J Travel Med. 2014 Mar-Apr;21(2):116-29. Review.

PMID:
24745041
[PubMed - indexed for MEDLINE]
11.

Treatment of leishmaniasis with miltefosine: 2008 status.

Berman JJ.

Expert Opin Drug Metab Toxicol. 2008 Sep;4(9):1209-16. doi: 10.1517/17425255.4.9.1209. Review.

PMID:
18721114
[PubMed - indexed for MEDLINE]
12.

Itraconazole in the treatment of cutaneous leishmaniasis.

Firooz A, Khatami A, Dowlati Y.

Int J Dermatol. 2006 Dec;45(12):1446-7. No abstract available.

PMID:
17184256
[PubMed - indexed for MEDLINE]
13.

Cutaneous leishmaniasis treated with itraconazole.

Baroni A, Aiello FS, Vozza A, Vozza G, Faccenda F, Brasiello M, Ruocco E.

Dermatol Ther. 2009 Nov;22 Suppl 1:S27-9. doi: 10.1111/j.1529-8019.2009.01264.x.

PMID:
19891689
[PubMed - indexed for MEDLINE]
14.

Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis.

Fischer C, Voss A, Engel J.

Med Microbiol Immunol. 2001 Nov;190(1-2):85-7. Review.

PMID:
11770118
[PubMed - indexed for MEDLINE]
15.

Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review.

Almeida OL, Santos JB.

An Bras Dermatol. 2011 May-Jun;86(3):497-506. Review. English, Portuguese.

PMID:
21738967
[PubMed - indexed for MEDLINE]
Free Article
16.

Searching the biomedical literature: research study designs and critical appraisal.

Callas PW.

Clin Lab Sci. 2008 Winter;21(1):42-8.

PMID:
18335861
[PubMed - indexed for MEDLINE]
17.

Treatment of cutaneous leishmaniasis patients with pentostam via intralesion infiltration.

Nagaty IM, Lashin AH.

J Egypt Soc Parasitol. 2000 Apr;30(1):177-82.

PMID:
10786029
[PubMed - indexed for MEDLINE]
18.

Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006.

Modabber F, Buffet PA, Torreele E, Milon G, Croft SL.

Kinetoplastid Biol Dis. 2007 Apr 24;6:3.

PMID:
17456237
[PubMed]
Free PMC Article
19.

More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects.

Olliaro P, Vaillant MT, Sundar S, Balasegaram M.

PLoS Negl Trop Dis. 2012;6(5):e1545. doi: 10.1371/journal.pntd.0001545. Epub 2012 May 29. Review. No abstract available.

PMID:
22666508
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Cutaneous leishmaniasis: successful treatment with itraconazole.

Consigli J, Danielo C, Gallerano V, Papa M, Guidi A.

Int J Dermatol. 2006 Jan;45(1):46-9.

PMID:
16426375
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk